152 related articles for article (PubMed ID: 31974916)
1. Geographically Focused Collocated Hepatitis C Screening and Treatment in Los Angeles's Skid Row.
Benitez TM; Fernando SM; Amini C; Saab S
Dig Dis Sci; 2020 Oct; 65(10):3023-3031. PubMed ID: 31974916
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study.
Bajis S; Grebely J; Cooper L; Smith J; Owen G; Chudleigh A; Hajarizadeh B; Martinello M; Adey S; Read P; Gilliver R; Applegate T; Treloar C; Maher L; Dore GJ
J Viral Hepat; 2019 Aug; 26(8):969-979. PubMed ID: 30980785
[TBL] [Abstract][Full Text] [Related]
3. Factors Associated with Sustained Virologic Response to Hepatitis C Treatment in a Homeless-Experienced Cohort in Boston, 2014-2020.
Beiser ME; Shaw LC; Wilson GA; Muse KO; Shores SK; Baggett TP
J Gen Intern Med; 2023 Mar; 38(4):865-872. PubMed ID: 36127534
[TBL] [Abstract][Full Text] [Related]
4. Exploratory assessment: Nurse-led community health worker delivered HCV intervention for people experiencing homelessness.
Nyamathi A; Salem BE; Lee D; Yu Z; Hudson A; Saab S; Shin SS; Jones-Patten A; Yadav K; Alikhani M; Clarke R; Chang A; White K; Gelberg L
Public Health Nurs; 2023; 40(5):641-654. PubMed ID: 37132164
[TBL] [Abstract][Full Text] [Related]
5. Race and Hepatitis C Care Continuum in an Underserved Birth Cohort.
Kim NJ; Locke CJ; Park H; Magee C; Bacchetti P; Khalili M
J Gen Intern Med; 2019 Oct; 34(10):2005-2013. PubMed ID: 30238404
[TBL] [Abstract][Full Text] [Related]
6. Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting.
Read P; Lothian R; Chronister K; Gilliver R; Kearley J; Dore GJ; van Beek I
Int J Drug Policy; 2017 Sep; 47():209-215. PubMed ID: 28587943
[TBL] [Abstract][Full Text] [Related]
7. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
[TBL] [Abstract][Full Text] [Related]
8. Impact of hepatitis B and C infection on health services utilization in homeless adults: a test of the Gelberg-Andersen Behavioral Model for Vulnerable Populations.
Stein JA; Andersen RM; Robertson M; Gelberg L
Health Psychol; 2012 Jan; 31(1):20-30. PubMed ID: 21574705
[TBL] [Abstract][Full Text] [Related]
9. Shelter-Based Integrated Model Is Effective in Scaling Up Hepatitis C Testing and Treatment in Persons Experiencing Homelessness.
Khalili M; Powell J; Park HH; Bush D; Naugle J; Ricco M; Magee C; Braimoh G; Zevin B; Fokuo JK; Masson CL
Hepatol Commun; 2022 Jan; 6(1):50-64. PubMed ID: 34628726
[TBL] [Abstract][Full Text] [Related]
10. Results of a Model of Delivering Hepatitis C Care in a Homeless Metropolitan Population in England.
Guerra-Veloz MF; Han K; Oakes K; Robertson D; Mohamed A; Cannon M; Barnabas A; Shah S; Halford R; Dusheiko G; Agarwal K
Am J Gastroenterol; 2023 Jun; 118(6):991-1000. PubMed ID: 36191276
[TBL] [Abstract][Full Text] [Related]
11. A hepatitis C elimination model in healthcare for the homeless organization: A novel reflexive laboratory algorithm and equity assessment.
Seaman A; King CA; Kaser T; Geduldig A; Ronan W; Cook R; Chan B; Levander XA; Priest KC; Korthuis PT
Int J Drug Policy; 2021 Oct; 96():103359. PubMed ID: 34325969
[TBL] [Abstract][Full Text] [Related]
12. Innovative Approaches to Engaging Homeless and Marginally Housed Patients in Care: a Case Study of Hepatitis C.
Conti J; Dryden E; Fincke BG; Dunlap S; McInnes DK
J Gen Intern Med; 2023 Jan; 38(1):156-164. PubMed ID: 35879538
[TBL] [Abstract][Full Text] [Related]
13. An educate, test and treat model towards elimination of hepatitis C infection in Egypt: Feasibility and effectiveness in 73 villages.
Shiha G; Soliman R; Mikhail NNH; Easterbrook P
J Hepatol; 2020 Apr; 72(4):658-669. PubMed ID: 31734097
[TBL] [Abstract][Full Text] [Related]
14. Improved Hepatitis C Cure Cascade Outcomes Among Urban Baby Boomers in the Direct-Acting Antiviral Era.
Dupont SC; Fluker SA; Quairoli KM; Body C; Okosun I; Lom J; Miller LS
Public Health Rep; 2020 Jan; 135(1):107-113. PubMed ID: 31756116
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus care cascade in persons experiencing homelessness in the United States in the era of direct-acting antiviral agents: A scoping review.
Del Rosario A; Eldredge JD; Doorley S; Mishra SI; Kesler D; Page K
J Viral Hepat; 2021 Nov; 28(11):1506-1514. PubMed ID: 34314081
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C treatment outcomes among homeless-experienced individuals at a community health centre in Boston.
Beiser ME; Smith K; Ingemi M; Mulligan E; Baggett TP
Int J Drug Policy; 2019 Oct; 72():129-137. PubMed ID: 30962036
[TBL] [Abstract][Full Text] [Related]
17. Assessing Racial Disparities in HCV Infection and Care Outcomes in a Southern Urban Population.
McGonigle K; Carley T; Hoff C
J Racial Ethn Health Disparities; 2018 Oct; 5(5):1052-1058. PubMed ID: 29288470
[TBL] [Abstract][Full Text] [Related]
18. Real-world use of elbasvir-grazoprevir in patients with chronic hepatitis C: retrospective analyses from the TRIO network.
Flamm SL; Bacon B; Curry MP; Milligan S; Nwankwo CU; Tsai N; Younossi Z; Afdhal N
Aliment Pharmacol Ther; 2018 Jun; 47(11):1511-1522. PubMed ID: 29665097
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, distribution, and correlates of hepatitis C virus infection among homeless adults in Los Angeles.
Gelberg L; Robertson MJ; Arangua L; Leake BD; Sumner G; Moe A; Andersen RM; Morgenstern H; Nyamathi A
Public Health Rep; 2012; 127(4):407-21. PubMed ID: 22753984
[TBL] [Abstract][Full Text] [Related]
20. Achieving a high cure rate with direct-acting antivirals for chronic Hepatitis C virus infection in Cameroon: a multi-clinic demonstration project.
Coyer L; Njoya O; Njouom R; Mossus T; Kowo MP; Essomba F; Boers A; Coutinho R; Ondoa P;
Trop Med Int Health; 2020 Sep; 25(9):1098-1109. PubMed ID: 32502290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
